[The use of ganglionic-blocking agents for the potentiation of insulin effect in the treatment of schizophrenia].
D004357:Drug Synergism; D005730:Ganglionic Blockers / Q000627:therapeutic use*; D006801:Humans; D007328:Insulin / Q000627:therapeutic use*; D012559:Schizophrenia / Q000188:drug therapy*
D005730:Ganglionic Blockers; D007328:Insulin
Prehled písemnictví o potenciaci úcinku inzulínu ganglioplegiky pri lécení schizofrenie hypoglykemickými kómaty.